VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,652 | -99.2% | 10,628 | -98.8% | 0.00% | -100.0% |
| Q1 2023 | $14,927,191 | +67.7% | 896,528 | -5.3% | 0.04% | +52.0% |
| Q4 2022 | $8,902,063 | +261.0% | 947,028 | +4.5% | 0.02% | +257.1% |
| Q3 2022 | $2,466,000 | -23.9% | 906,628 | -19.1% | 0.01% | -22.2% |
| Q2 2022 | $3,240,000 | -2.5% | 1,121,028 | +1.2% | 0.01% | 0.0% |
| Q1 2022 | $3,324,000 | -17.7% | 1,108,028 | +26.1% | 0.01% | -10.0% |
| Q4 2021 | $4,041,000 | -31.5% | 878,428 | -6.4% | 0.01% | -33.3% |
| Q3 2021 | $5,896,000 | 0.0% | 938,828 | -4.6% | 0.02% | -6.2% |
| Q2 2021 | $5,896,000 | -9.2% | 984,228 | -4.1% | 0.02% | -11.1% |
| Q1 2021 | $6,491,000 | +148.7% | 1,026,228 | +121.4% | 0.02% | +157.1% |
| Q4 2020 | $2,610,000 | +450.6% | 463,528 | +468.6% | 0.01% | +600.0% |
| Q3 2020 | $474,000 | +66.3% | 81,528 | +106.4% | 0.00% | 0.0% |
| Q2 2020 | $285,000 | +176.7% | 39,500 | +194.8% | 0.00% | – |
| Q4 2018 | $103,000 | -81.6% | 13,400 | -58.4% | 0.00% | -100.0% |
| Q3 2018 | $561,000 | +143.9% | 32,200 | +33.1% | 0.00% | 0.0% |
| Q2 2018 | $230,000 | +180.5% | 24,200 | +28.7% | 0.00% | – |
| Q1 2018 | $82,000 | – | 18,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |